Study identification

EU PAS number

EUPAS34607

Study ID

40909

Official title and acronym

Determination of phenotypes predicting complications in COVID-19 and evaluation of the efficacy of immunosuppressive treatments (INMUNOSUPR COVID-19)

DARWIN EU® study

No

Study countries

Spain

Study description

The aim of the project is (1) to identify phenotypes that predict the need for mechanical ventilation in the initial evaluation of patients and their evolution in the first days of admission, and (2) to evaluate the efficacy and safety of immunosuppressive treatments used in patients without mechanical ventilation with elevated markers of macrophage activation syndrome. They will be carried out through multi-centre retrospective cohort studies, with advanced statistical analysis for observational studies.

Study status

Finalised
Research institutions and networks

Institutions

HU Juan Ramón Jiménez Huelva, HU Puerta del Mar Cádiz, HU Puerto Real Cádiz, HU de Jeréz Cádiz, HU Regional de Málaga Málaga, HU Costa del Sol Málaga, HU Virgen de Valme Sevilla, HU San Cecilio Granada, CHU A coruña A Coruña, HU de las Cruces Vizcaya

Networks

ANCRAID

Contact details

Jesús Rodríguez-Baño jesusrb@us.es

Study contact
jesusrb@us.es

Jesús Rodríguez-Baño

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of interim report, if expected

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Other

More details on funding

ISCIII
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable